MicroPort Endovascular MedTech Ltd (SHG:688016) — Market Cap & Net Worth
Market Cap & Net Worth: MicroPort Endovascular MedTech Ltd (688016)
MicroPort Endovascular MedTech Ltd (SHG:688016) has a market capitalization of $1.61 Billion (CN¥10.99 Billion) as of June 23, 2026. Listed on the SHG stock exchange, this China-based company holds position #7095 globally and #1621 in its home market, demonstrating a -3.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MicroPort Endovascular MedTech Ltd's stock price CN¥89.18 by its total outstanding shares 123262117 (123.26 Million). Review MicroPort Endovascular MedTech Ltd debt and liabilities to assess the company's total debt and financial obligations.
MicroPort Endovascular MedTech Ltd Market Cap History: 2019 to 2026
MicroPort Endovascular MedTech Ltd's market capitalization history from 2019 to 2026. Data shows change from $2.57 Billion to $1.61 Billion (-7.57% CAGR).
MicroPort Endovascular MedTech Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MicroPort Endovascular MedTech Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.22x
MicroPort Endovascular MedTech Ltd's market cap is 1.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.94x
MicroPort Endovascular MedTech Ltd's market cap is 2.94 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.57 Billion | $333.73 Million | $141.76 Million | 7.71x | 18.15x |
| 2020 | $4.41 Billion | $470.25 Million | $214.61 Million | 9.37x | 20.54x |
| 2021 | $4.38 Billion | $684.63 Million | $315.86 Million | 6.39x | 13.85x |
| 2022 | $3.36 Billion | $896.50 Million | $356.88 Million | 3.75x | 9.42x |
| 2023 | $3.51 Billion | $1.19 Billion | $492.43 Million | 2.96x | 7.13x |
| 2024 | $1.98 Billion | $1.21 Billion | $502.10 Million | 1.64x | 3.95x |
| 2025 | $1.65 Billion | $1.35 Billion | $563.21 Million | 1.22x | 2.94x |
Competitor Companies of 688016 by Market Capitalization
Companies near MicroPort Endovascular MedTech Ltd in the global market cap rankings as of June 23, 2026.
Key companies related to MicroPort Endovascular MedTech Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #147 globally with a market cap of $153.73 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #207 globally with a market cap of $117.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #234 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #247 globally with a market cap of $101.86 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #147 | Abbott Laboratories | NYSE:ABT | $153.73 Billion | $88.41 |
| #207 | Stryker Corporation | NYSE:SYK | $117.79 Billion | $307.80 |
| #234 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #247 | Medtronic PLC | NYSE:MDT | $101.86 Billion | $79.34 |
MicroPort Endovascular MedTech Ltd Historical Marketcap From 2019 to 2026
Between 2019 and today, MicroPort Endovascular MedTech Ltd's market cap moved from $2.57 Billion to $ 1.61 Billion, with a yearly change of -7.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.61 Billion | -2.71% |
| 2025 | CN¥1.65 Billion | -16.56% |
| 2024 | CN¥1.98 Billion | -43.56% |
| 2023 | CN¥3.51 Billion | +4.39% |
| 2022 | CN¥3.36 Billion | -23.14% |
| 2021 | CN¥4.38 Billion | -0.74% |
| 2020 | CN¥4.41 Billion | +71.31% |
| 2019 | CN¥2.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 22nd, 2026 the market cap of MicroPort Endovascular MedTech Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.61 Billion USD |
| MoneyControl | $1.61 Billion USD |
| MarketWatch | $1.61 Billion USD |
| marketcap.company | $1.61 Billion USD |
| Reuters | $1.61 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MicroPort Endovascular MedTech Ltd
Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, sale, and services of aortic, peripheral vascular, and tumor intervention devices in China and internationally. The company offers Fontus, a branched stent graft system in surgical operation; CRONUS, a stent graft system in surgical operation; Hector, a multi-branch thoracic stent graft syste… Read more